Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07800247

Hemoglobin Disorders in Egypt: Sickle Cell Disease Ain Shams University Institutional Registry

This is a retrospective descriptive study to create an institutional registry that will continue as a prospective follow-up non-intervention study that will be carried out at Hematology Oncology and BMT Department, Children's Hospital, Ain-Shams University, Cairo, Egypt.

Recruiting

Interested in participating?

Request Info

Key information

Age range

Up to 39 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine Ain Shams Research Institute- Clinical Research Center, Cairo, Egypt

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • children, adolescents and young adults with sickle cell disease

Exclusion criteria

  • other inherited anemia

Treatment and study plan

Primary outcomes

  1. Institutional database

    Time frame: 2 years

    To create databases and institutional registry for managing the clinical data

Study contacts

Contact information is provided by the study sponsor or research team.

Dr. Fatma Ebeid Ebeid

CONTACT

[email protected]

+20 109 5569596

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Acronym: Egyptian SCD

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Sep 2, 2026
Registry last updated
Sep 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.